CancerfromBoston.com9 hours agoEli Lilly to acquire Boston biotech Kelonia Therapy in $7 billion dealEli Lilly will acquire Kelonia Therapeutics for $7 billion to enhance its cancer treatment capabilities in Massachusetts.